MANAGEMENT ASTHMA AND COVID-19 IN

PANDEMIC ERA: A CASE REPORT

Endah Setyaningsih, Annisa Rahmania Yulman
Universitas Indonesia Hospital, Depok, Indonesia

BACKGROUND
Coronavirus disease 2019 (COVID-19) is caused by a newly emergent coronavirus.
Underlying diseases, such as asthma may affect the diagnosis, progress,
treatment, and prognosis of COVID-19.

CASE
Case 1:
12-year-old girl
Clinical presentation wheeze, cough, ageusia,
abdominal pain, and nausea
Physical examination T 36.7 C, RR 30x/min, HR
140x/min, SpO2 99% with nasal
canule 4 lpm and wheezing in
both lungs
Laboratory findings leucocytosis, thrombocytosis, and leucocytosis, neutrophilia, and
neutrophilia. RT PCR for SARS
CoV-2 was positive
Radiography finding Opacity in basal lung
Case 2:
13-year-old girl
wheeze after exercise and cough,
no history of fever or other
respiratory and gastrointestinal
problems
T 36.3 C, RR 30x/min, HR
126x/min, SpO2 96% in room air,
and wheezing in both lungs
CRP was elevated PCR SARS CoV-2
positive
Infiltrate in both lungs

Diagnose COVID-19 pneumonia with COVID-19 with moderate

moderate symptom, asthma
persistent with severe
exacerbation
Medication Remdesivir, methylprednisolone,
salbutamol and ipratropium
bromide nebulization, fluticasone
propionate inhaler, and
ceftriaxone
Outcome improved and respond with
antiviral after 7 days of treatment.
RT PCR was negative after 1 week
hospitalization.
symptom, asthma intermittent
with mild to moderate
exacerbation, and exercise induce
bronchospasm
Favipiravir, methylprednisolone,
salbutamol nebulization, and
ceftriaxone
improved and respond with
antiviral after 7 days of treatment.
RT PCR was negative after 1 week
hospitalization

DISCUSSION
Diagnosis of pediatric asthma during pandemic may be complicated by similarity
in symptoms between COVID-19 and worsening asthma. There is a theoretical
possibility that a child with asthma infected by COVID-19 could experience an
asthma exacerbation and serious morbidity due to combined effect on the
respiratory tract.